Haitong International Securities Group

Haitong International Securities Group Limited is a financial services firm based in Hong Kong that offers a diverse range of products and services to corporate, institutional, and retail clients globally. The company operates through several segments, including Wealth Management, which provides investment solutions and advisory services to high net-worth individuals; Corporate Finance, which offers underwriting and advisory services for equity and debt fundraising, as well as corporate actions; and Asset Management, which delivers investment management services for various funds. The Institutional Clients segment focuses on cash equities trading, brokerage, equity research, and financial instruments tailored for institutional clients. Additionally, the company engages in investment activities through its Investment segment. Founded in 1973 and formerly known as Taifook Securities Group Limited, Haitong International operates as a subsidiary of Haitong International Holdings Limited and serves clients across multiple sectors, including consumer products, energy, and technology.

Peter Goodfellow

Managing Director and Finance Director, International Business

Johnnie Yung

Managing Director, Investments

14 past transactions

MetaX

Series B in 2022
Developer of graphics chips, processors, and semiconductor technology designed for advanced GPU power. The company is mainly engaged in developing advanced GPU chips used in various fields including high-end PCs, data centers, and workstations, providing users with advanced GPU power at a fair cost.

YS Biopharma

Series B in 2021
Yisheng Biopharma Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of immuno-oncology products and vaccines. Founded in 2002 and headquartered in Beijing, the company operates in China, the United States, Cambodia, and Singapore. Yisheng Biopharma utilizes its novel PIKA immunomodulating technology to enhance immune responses against cancers and infectious diseases. Key products under development include YS-ON-001, an investigational therapy aimed at treating advanced solid tumors, as well as YS-HBV-001, a vaccine for hepatitis B, and a PIKA-based rabies vaccine designed for rapid protection against rabies infection. The company's innovative approach targets multiple immune pathways to improve treatment outcomes.

Travel Easy

Private Equity Round in 2019
Travel Easy is a service platform for cross-border shopping

ORIG3N

Series B in 2018
ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly affecting the heart, liver, and neurodegenerative conditions. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology, enabling the differentiation of cells into any type found in the body. This technology serves multiple purposes, including drug efficacy testing, medication toxicity screening, and facilitating personalized treatment approaches. The company's product offerings include LifeProfiles, a suite of genetic tests such as FITCODE, which provides insights into fitness-related traits; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.

TCR2

Series B in 2018
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company focused on developing innovative T cell receptor therapies for cancer treatment. The company's lead product candidates include TC-210, a TRuC-T cell therapy targeting mesothelin-positive solid tumors, which is currently undergoing a phase I/II clinical trial for various cancers, including non-small cell lung cancer, ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Another key candidate is TC-110, designed to target CD19-positive B-cell hematological malignancies. TCR2's pipeline also addresses adult acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma. The company, founded in 2015 and headquartered in Cambridge, Massachusetts, leverages advanced technologies and a deep understanding of T cell receptor biology to create therapies that differ from traditional CAR-T treatments and enhance T cell engagement in recognizing and destroying cancer cells.

Souche

Series D in 2017
Souche, a leading automotive new retail platform in China, is founded by Mr. Yao Junhong, the former CAR Inc. founding team member and vice president, in December, 2012. By August 2018, Souche raised over $1.2 billion from investment or ganizations, including Alibaba group, Ant Financial Services Group, Morningside Venture Capital, Warburg Pincus, Primavera Capital Group, etc. Souche joined '2017 New Global Unicorns Ranking' by Silicon Valley global research organization PitchBook. Souche thrives to become the big intelligent brain of automotive industry. Souche has gradually constructed integrated automotive new retail ecosystem through years of development. Souche is regarded as 'the Alibaba of Chinese automotive industry'. Today, Souche and its relative corporations dedicate in numerous businesses, which include automotive financial leasing platform Tangeche, B2B industrial chain service platform Chehang168, Used-car online trade platform Cheyipai, Car sharing customized platform TIHD, SaaS products for used-car automotive dealers Dafengche and new-car sub-channels automotive dealership network Maicheguanjia, automotive dealership group ERP system provider Breakthrough, Kingdee and automotive supply chain warehouse logistics integrated service provider Iyunche, etc.

Nio

Series C in 2017
Nio Limited is a prominent electric vehicle manufacturer based in Shanghai, China, focusing on the premium segment of the market. Founded in 2014, the company designs, jointly manufactures, and sells smart electric vehicles, including five, six, and seven-seater SUVs. Nio is recognized for its innovative technology, including battery swapping and autonomous driving features, which enhance user experience. Its model lineup includes the ES8, a high-performance seven-seater SUV launched in 2018, the ES6 five-seater SUV, and the EC6 electric coupe SUV. The company also provides a range of charging solutions, such as home charging, battery swapping services, and mobile charging options, alongside value-added services like insurance and maintenance. In addition to its electric vehicle offerings, Nio collaborates with organizations like Mobileye N.V. to advance its technology. As of 2023, Nio has sold over 160,000 electric vehicles, capturing approximately 2% of the new energy vehicle market in China.

SmartStudy

Series B in 2016
Smartstudy Technology (Beijing) Co., Ltd. is the best children's mobile education brand in Asia. Successfully entered the United States, Europe, Southeast Asia and other 158 countries and regions. Its Fox image related products has ranked the top three educational applications for many years. The company is based in Beijing, China.

Wifi Skeleton Key

Series A in 2015
Wifi Skeleton key is an app for that allows the connection to wifi hotspots in China without signing in. WiFi Wan Can key was released in 2012, and has close to 600 million total subscribers. WiFi master key is a WiFi network connection management software that helps users to automatically query information surrounding open free public Wi-Fi hotspots.

lvyouquan

Series A in 2014
Lvyouquan initially focused on providing marketing and sales services

91JinRong

Series B in 2014
91JinRong.com Inc. is an online financial product sales and services platform based in Beijing, China, with an additional office in Shanghai. Founded in 2011, the company operates as a financial intermediary, connecting consumers with suitable financial institutions to offer personalized loan and insurance services. By leveraging the personal information and needs of users, 91JinRong matches them with appropriate products from a network of over 300 financial partners, including prominent banks and insurance companies. The platform facilitates significant daily transaction volumes, handling over RMB 300 million in loans and more than 2,000 insurance transactions, thereby serving hundreds of thousands of consumers seeking financial solutions.

Morning Tec

Series A in 2014
MorningTec (上海晨之科) specializes in releasing mobile internet game products and developing new technologies. Aiming at creating better products and technologies and expecting to bring innovative experience to users and the industry, the company pursues cutting-edge technology. Recently, it has released StellaSDK, a high-efficient cross-platform developing tool, and the Firebird browser which supports loadings of native applications.
Teamsun Technology (华胜天成) is a Chinese provider of information technology applications and services for the development of computer information systems and enterprise-level communication systems. Founded in November 1998, the company has registered a capital of 94 million Yuan, and in April 2004, it was listed on the Shanghai Security Exchange. The business direction of Beijing Teamsun Technology Co., Ltd. involves fields such as cloud computing, mobile internet, Internet-of-Things, and information safety, with over 5,000 employers. It also owns over 20 holding subsidiaries directly or indirectly. Since its listing, the company’s compound annual growth rate (CAGR) has reached more than 23%, and the current business size has exceeded 5 billion Yuan.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.